| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $49.8M | +2.8% |
| SG&A Expense | $8.7M | +1.9% |
| Operating Income | -$58.3M | -2.8% |
| Net Income | -$62.6M | -10.5% |
| EPS (Basic) | -$7.09 | +4.8% |
| EPS (Diluted) | -$7.09 | +4.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.1M | -78.0% |
| Current Assets | $13.3M | -76.2% |
| Total Assets | $13.3M | -76.2% |
| Current Liabilities | $32.8M | +26.1% |
| Total Liabilities | $32.8M | +26.1% |
| Stockholders' Equity | -$19.5M | -165.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.6M | -118.8% |
| Financing Cash Flow | $14.9M | -63.0% |